MEETINGS - US coronary drug-eluting stents regulatory workshop
This article was originally published in Clinica
US medtech industry association AdvaMed and the FDA are holding a joint workshop to clarify the draft recommendations issued by the agency last month on "coronary drug-eluting stents, non-clinical and clinical studies. The event takes place on April 29 at the FDA's White Oak Campus, in Silver Spring, Maryland. The deadline for registration of non-US attendees as visitors was April 11. Further information and registration via the meetings and events pages of www.advamed.org
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.